使用MMA栓塞±手术治疗慢性体内血瘤的治疗:先前的他类药物治疗没有减少复发
Fee Christiane Keil1, Emma Becke1, Rejane Golbach2
1Goethe University Frankfurt, University Hospital, Institute of Neuroradiology Frankfurt am Main, Germany.
Brain & spine
|January 14, 2026
概括
预先存在的他类药物治疗没有减少中脑膜动脉栓塞 (MMAE) 后慢性脑膜下血瘤 (CSDH) 复发. 与单独使用MMAE不同,与MMAE结合的手术没有出现复发,但需要进一步的研究.
科学领域:
- 神经外科 神经外科
- 干预神经病学 干预神经病学
- 血管神经学 血管神经学
背景情况:
- 慢性亚皮血瘤 (CSH) 复发是一个临床挑战.
- 类药物正在探索其降低CSH复发率的潜力.
- 中脑膜动脉栓塞 (MMAE) 是对CSH的新兴治疗方法.
研究的目的:
- 调查先前存在的他类药物治疗是否会影响MMAE后的CSH复发.
- 为了比较单独的MMAE和外科疏散加MMAE的联合手术之间的复发率.
主要方法:
- 在2020年1月至2021年10月期间,对47例用MMAE治疗的CSH病例进行了回顾性分析.
- 斯坦丁暴露被定义为在MMAE之前记录的使用,并在随访期间继续使用.
- 临床治疗失败被定义为具有新神经症状的放射性复发.
主要成果:
- 整体复发率为6.4% (3/47个病例).
- 达丁类药物的使用 (在38.3%的患者中) 与复发率的减少没有显著关联.
- 在用手术和MMAE联合治疗的病例中没有观察到复发,而仅使用MMAE就有事件.
结论:
- 在这组接受MMAE的队列中,使用他类药物与减少CSH复发无关.
- 结合手术疏散和MMAE,通过避免复发,证明了潜在的益处.
- 这些探索性发现需要前性研究来确认,因为样本规模很小.
相关概念视频
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...


